Objective: Left ventricular hypertrophy has been associated with the prolongation of QT-time, and an increased risk of ventricular arrhythmias. The renin angiotensin system has been implicated in the development of ventricular hypertrophy. At 5 weeks complete AV block (CAVB) in the dog, there is: (1) biventricular hypertrophy associated with a transient activation of components of the renin angiotensin system, (2) increased APD, more pronounced in the left than in the right ventricle leading to spatial dispersion of repolarization, and (3) enhanced susceptibility to drug-induced torsade de pointes arrhythmias. To investigate whether these remodeling processes develop in parallel, time dependency was assessed in absence or presence of the AT1 receptor-blocker Irbesartan. Methods and results: Dogs in sinus rhythm, 2 and 5 weeks CAVB were compared to dogs chronically treated with Irbesartan (30 mg / kg BID). Endocardial monophasic APD of left and right ventricle was measured and susceptibility to torsade de pointes was tested by infusing Dofetilide (0.025 mg / kg / 59). Hypertrophy was determined by relating heart-to-body weight at sacrifice. Left ventricular APD had increased more than right ventricular APD at 2 and 5 weeks CAVB, leading to an increase in spatial dispersion. At that time torsade de pointes were evocable in the majority of the dogs. Hypertrophy had only developed completely at 5 weeks CAVB. Irbesartan had no effect on electrical and structural parameters or on arrhythmogenicity. Conclusions: In the CAVB dog ventricular hypertrophy is not a prerequisite for electrical remodeling or drug-induced torsade de pointes, and the AT1-receptor has no dominant role in the completion of these remodeling processes.
. Introduction
relation between ventricular hypertrophy and the occurrence of electrophysiological changes, like the prolongaLeft ventricular hypertrophy is a common finding in the tion of ventricular repolarization, has been confirmed [3] . adult population and associated with an increased QT-time
In the chronic complete AV block (CAVB) dog, electrical and enhanced risk of ventricular arrhythmias and sudden remodeling is further characterized by an increase in cardiac death [1, 2] . In numerous animal models the spatial dispersion and a higher propensity to (drug-induced) early afterdepolarizations, ectopic beats and Torsade de Pointes-arrhythmias (TdP) [4, 5] . Although the association between the presence of ventricular hyper- course of development has never been studied. Therefore CA, USA) for 2 min, between the large tip thermocouple we determined the temporal behaviour of these processes electrode of the ablation catheter and an adhesive pad after creation of AV-block.
applied on the back of the dog. For electrophysiological Secondly, we attempted to dissociate these remodeling parameters (EP), the regular 6-lead surface ECG was processes pharmacologically using Irbesartan (I), an anaccompanied by 2 monophasic action potentials (MAPs, giotensin II type-1 receptor (AT1)-blocker. This approach EP Technologies) placed at the endocardium of the left and was selected since in the CAVB dog-model: the renin right ventricle (LV and RV, respectively). The EP measureangiotensin system (RAS) is transiently activated [4] , and ments at AAVB and CAVB were performed at two basic AT1 mRNA expression levels relate to the degree of rates: (1) the idioventricular rate (IVR), and (2) a fixed ventricular hypertrophy [6] .
pacing rate (FRP) with an interstimulus interval of 500 ms. During FRP, which was performed for 2 min from the RV MAP, the ventricular effective refractory period (VERP) 2 . Methods was determined incrementally (steps of 5 ms) at twice diastolic threshold. For hemodynamics, pressure (P) sig-2 .1. General nals were recorded with a Sentron catheter (Sentron Europe), which was positioned in the abdominal aorta for a Thirty mongrel dogs (body weight 21-33 kg, 15 short period (only during SR) and advanced to the LV females) underwent experimental testing. Irbesartan cavity where it remained thereafter. All hemodynamic datá (Sanofi-Synthelabo, Montpellier, France) was administered were gathered during IVR. In the CAVB5 group, no orally at a dose of 30 mg / kg BID [7] to 10 dogs, starting 1 hemodynamic data were collected since an extensive data week prior to AV block creation. Serial measurements were set already existed [9] . Definitions, amplifications and filter performed under premedication (ECG) or during complete settings were described in previous publications [4, 8, 10] . anesthesia. Surface ECGs were recorded during regular An arrhythmogenic challenge was performed at CAVB sinus rhythm (SR) before and during Irbesartan (I), and by applying 0.025 mg / kg dofetilide intravenous for 5 min repetitively after creation of AV-block until 2 weeks AV- [8] . The occurrence of TdP was scored for 20 min. When block. Invasive measurements were performed at different TdP was seen 3 or more times, the dog was considered time points: SR, acute AV-block (AAVB), CAVB2, and / or susceptible. CAVB5 in which 2 and 5 indicates 2 or 5 weeks CAVB At sacrifice, the heart was excised and weighed. The respectively. At the moment of sacrifice, dogs belonged to ventricles were isolated from the atria, RV was removed, the following groups: SR (n 5 5), CAVB2 (n 5 8), CAVB5 and the septum was taken as part of the LV. (n 5 7), CAVB2I (n 5 5), and CAVB5I (n 5 5). Since dogs were tested serially the numbers depicted in the tables 2 .3. Data analysis often exceed the group size.
Animal handling was in accordance with the In this study, focus was on the electrophysiological During SR the pharmacologic activity of Irbesartan was changes taking place in the first 2 weeks after creation of characterized in preliminary experiments. The response of AV-block. In the left panel of Fig. 1 changes in PP, RR, the aortic systolic pressure to intravenous incremental and QT-time are depicted at different time points under boluses of angiotensin II was measured in 3 dogs before sedation. Acute AV-block resulted in a significant atrial and 1 week after the administration of Irbesartan.
cycle length decrease, while RR and QT did not significantly increase (left panels). Initially, this lack of severe 2 .6. Statistics ventricular bradycardia came as a surprise. From personal observations we learned that this was only the case during Pooled data are expressed as mean6S.D. Serial comthe first 24 h after creation of AV-block, thereafter the parisons were performed by paired student's t-test and RR-time increased significantly. This lack of bradycardia could well be related to the severe decrease in PP-time (increased adrenergic state). In time (1 week CAVB: CAVB1) the evolving ventricular bradycardia led to a further lengthening of QT-time, while the PP-time was returning to normal. At CAVB2 there was a further increase in QT-time while the RR remained stable (electrical remodeling). The presence of electrical remodeling was confirmed at CAVB2 when the heart rate was controlled at 500 ms fixed rate pacing (FRP) under complete anesthesia (right panel Fig. 1 ). The QT-time, LV MAPD, RV MAPD, and VERP were significantly increased at CAVB2. Moreover, the increase of MAPD was more pronounced in LV than in RV, leading to an increase in spatial dispersion of repolarization (DMAPD: 14610 ms at AAVB and 26623 ms at CAVB2). The two components of the cardiac tissue RAS showed demonstrated by a significant increase in heart weight-toa change in mRNA expression after creation of AV-block. body weight ratio (H / Bw) as compared to SR, 11.661.1 Ventricular ACE mRNA expression was unchanged at vs. 7.960.7 g / kg (Fig. 2) . In contrast, the CAVB2 group CAVB2 as compared to SR, and decreased at CAVB5. The did not show cardiac hypertrophy (H / Bw: 8.860.9 g / kg).
mRNA expression of chymase however was increased at When comparing the individual H / Bw ratios, one apboth CAVB2 and CAVB5 (Fig. 3) (2) a downward shift of the dose-response curve the LV however was significantly higher at CAVB2 as seen (Fig. 4) . At a subdepressor dosage regimen, effective by an increased 1dP/ dtmax as compared to SR blockade of angiotensin II was reached. (254361054 vs. 14476396 mmHg / s respectively). None of the dogs showed physical signs of congestive heart failure either during the experimental period or at autopsy.
.2.2. Effect of Irbesartan on electrophysiological parameters during SR
Daily chronic administration of Irbesartan during SR did not alter EP. Serially (n 5 10) the heart rhythm (PP-time: 227628 ms) were not influenced after 1 week of treatment. 
.2.3. AT1-blockade and ventricular remodeling
Within 2 weeks after creation of AV-block, electrical remodeling occurred in the Irbesartan treated animals. The changes were similar to those seen in the control groups. In Table 2 , QT, LV MAPD, RV MAPD, DMAPD, and VERP during fixed rate pacing (FRP), serially conducted at AAVB and CAVB2 are depicted. All electrophysiological parameters increased significantly at CAVB2. From 2 to 5 to the arrhythmias in the control groups. A representative CAVB2, while cardiac hypertrophy has only developed at example is shown in Fig. 6 .
CAVB5. LVSP and LVEDP were unaltered at CAVB2I and CAVB5I when compared to the SR group. The LVSP was 10364 mmHg at CAVB2I, 98620 mmHg at CAVB5I and 4 . Discussion 95613 mmHg at SR, and the LVEDP was 963, 562 and 863 mmHg, respectively. Contractility of the LV had
In the CAVB dog, ventricular electrical remodeling and significantly increased at CAVB2I (LV 1dP/ dtmax: the arrhythmia-prone condition, i.e., Dofetilide-induced 24636512 mmHg / s), and CAVB5I (23386564 mmHg / s) TdP, are already present at CAVB2, while the development as compared to SR (15706188 mmHg / s). The hemoof cardiac hypertrophy seems to follow a slower time dynamic parameters were comparable to the control group.
course. Irbesartan, the AT1-blocker, does not prevent None of the Irbesartan treated animals showed signs of ventricular remodeling in this model, regardless of the fact congestive heart failure.
that components of the renin angiotensin system have been Observations concerning the development of cardiac implicated in hypertrophy. hypertrophy were similar in the Irbesartan groups as compared to control (Fig. 5) . Hypertrophy was present at CAVB5I (10.761.0 g / kg) but not at CAVB2I (8.360. 5 4 .1. Temporal dissociation of electrical remodeling from g / kg). A subanalysis revealed that the LV weight-to-body cardiac hypertrophy weight ratio at CAVB2I (4.760.3 g / kg) was significantly less than at CAVB5I (6.160.6 g / kg). The same was true
The long-term (.5 weeks) adaptations of the CAVB for the RV weight-to-body weight ratio: 1.860.2 g / kg at dog have been the subject of many publications [4-CAVB2I vs. 2.360.4 g / kg at CAVB5I. 6, 8, 9, 14, 15] . Electrical remodeling can be characterized by a non-homogeneous lengthening of MAPD (LV.RV) leading to spatial dispersion of repolarization. The inci-3 .3. Different time course of electrical remodeling and dence of class III antiarrhythmic-induced TdP is high, and cardiac hypertrophy the incidence of sudden cardiac death is 10-15%. There is eccentric biventricular hypertrophy, not accompanied by When plotting the values of the control and Irbesartan excessive collagen depositions or changes in capillarygroups at similar time points (Fig. 5) , the distinction in fiber ratio. At 5-6 weeks CAVB, mechanical adaptations temporal behaviour of the two remodeling processes can have led to a hemodynamically compensated state: LV and be appreciated. Electrical remodeling is complete at RV 1dP/ dtmax have increased, cardiac output is main-tained, and ventricular EDP is unchanged in comparison to elevated in the CAVB dog [4, 6] , (2) chymase mRNA was SR.
elevated at CAVB while ACE-expression was unchanged This study is the first one to describe the temporal or even decreased, possibly suggesting a predominance of dissociation of electrical remodeling and related proarchymase in tissue angiotensin II production after AV-block, rhythmia from cardiac hypertrophy in an in vivo dog (3) other pathways, like bradykinin, influenced by ACEmodel. An increased QT, ventricular MAPD prolongation, inhibitors are left untouched by AT1-blockade, and (4) spatial dispersion of repolarization, and susceptibility to
Irbesartan can be applied effectively at a dosage not drug-induced TdP were uniformly present at CAVB2.
influencing blood pressure thereby preserving hemodyCardiac hypertrophy on the other hand developed more namics. slowly: at CAVB2 hypertrophy was absent in the majority Though the activation of AT1 in the mammalian heart of the dogs, while at CAVB5 it was fully present. LV and mainly results in the development of myocyte hypertrophy RV weights showed comparable results. Lack of synchrony in vitro [22] , conflicting data have been published conhas been indicated in the first days after myocardial cerning the effect of blockade in vivo. Most prevention 1 infarction in the rat, where downregulation of K -channel studies have focused on the effect of AT1-blockade during genes and currents was present while no hypertrophy was pressure overload. For example, in some studies condetectable yet [16] . In two papers pharmacological sepacerning aorta banding in rats, hypertrophy was attenuated, ration of these processes during their developmental phase while in others no effect was seen [18, 23, 24] . AT1-blockwas reported. In a murine model of pressure overload, ers failed to prevent cardiac hypertrophy in constrictive cyclosporin A was able to prevent myocyte hypertrophy, pulmonary artery-banded rabbits, cats, and fetal sheep while the prolongation of the action potential was only [25] [26] [27] . Prevention studies in volume overload models are attenuated [17] . In aortic-banded rats changes in gene scarce. In rat models of volume overload AT1-blockade products of I , I and I were prevented by treatment with attenuated hypertrophy [28, 29] a Ca -antagonist, while LV hypertrophy developed [18] .
presence of myocyte hypertrophy after mitral valve regHowever none of these pharmacological studies described urgitation despite AT1-blockade in the dog [30] . In the the arrhythmogenic consequences of the dissociation.
CAVB dog no prevention of hypertrophy by Irbesartan was These studies and the present one, where electrical reseen at CAVB5I as compared to CAVB5. However, a modeling and hypertrophy develop asynchronously, indiblunted response cannot be ruled out. This all, leads us to cate the presence of different signalling routes. More believe that AT1 may not be the dominant factor in the recently, it was suggested that the reduction of ion channel development of mechanical overload-induced hypertrophy, gene products might even be the starting point of hybut that other signaling pathways are of importance. pertrophic signalling [19] .
Moreover, Irbesartan was not able to prevent electrical remodeling in this model. Furthermore, the relation be-4 .2. No sign of heart failure in the CAVB dog tween the presence of electrical remodeling and the susceptibility to Dofetilide-induced TdP remained present. Another important finding is that during short-term volume overload, when hypertrophy is not yet present 4 .4. Clinical implications (CAVB2), there are no signs of congestive heart failure: LVEDP is not elevated, LV 1dP/ dt max is significantly
In clinical studies an increased QT-time and the presincreased, and there are no physical signs of pump failure.
ence of ventricular arrhythmias has been documented in This suggests that during the early time course of mepatients with left ventricular hypertrophy [1, 2] . A positive chanical overload mechanisms other than hypertrophy correlation between the increase in LV mass and the QT come into play to compensate for the increased workload duration has been implicated [2] . This experimental study of the heart. Mouse models of pressure overload, either suggests that electrical remodeling and proarrhythmia are transgenic or treated with cyclosporin A, confirm that a likely to precede the presence of hypertrophy. preserved cardiac function is not necessarily accompanied So far, no clinical study has addressed temporal aspects by cardiac hypertrophy [20, 21] . Whether contractile imof electrical remodeling, proarrhythmia and hypertrophy. provements can be maintained in the long run without the We realize that conducting such a study will merely be involvement of cardiac hypertrophy is unclear. In this impossible due to ethical and practical constraints. Therestudy, where mechanical adaptations and cardiac hyperfore the CAVB dog is a very suitable model to study these trophy are both present at CAVB5, hypertrophy may be aspects in detail. necessary for the long-term compensation.
.5. Limitations .3. Lack of effect of Irbesartan
We do not know whether Irbesartan actually reached the For several reasons we selected AT1-inhibition: (1) AT1 on the membrane of the cardiomyocyte, though we tissue and plasma components of the RAS are (transiently) assume this was the case because its vascular counterpart contractility of the LV was as such not fully characterized.
[11] V an de Water A, Verheyen J, Xhonneux R, Reneman RS. An improved method to correct the QT interval of the electrocardiogram for changes in heart rate. J Pharmacol Methods 1989;22:207-217. is not a prerequisite for electrical remodeling or drug- 
. Conclusions

